High-risk Americans are having a tough time getting Covid-19 antiviral pills as prescribers grapple with limited guidance on who is eligible and how many are available, infectious disease specialists say.
More than 2,500 Test-to-Treat sites are set up across the country where patients can get tested and prescribed
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.